Patients with Cushing disease have an increased risk for new-onset autoimmune disease in the 3 years after surgical remission, according to a new retrospective study published on February 20 in Annals ...

Please provide your email address to receive an email when new articles are posted on . Of adults who achieved Cushing’s disease remission after surgery, 10.4% developed new-onset autoimmune disease.

A study of more than 250 persons undergoing surgical therapy for Cushing's disease (CD) or nonfunctioning pituitary adenomas (NFPAs) found that patients who achieved remission of CD were more likely ...

The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has ...

Researchers published the study covered in this summary on Research Square as a preprint that has not yet been peer reviewed. No single factor predicts the recurrence of Cushing disease during ...